Editorial & Opinion
Reply to B. Zhao et al.
العنوان: | Reply to B. Zhao et al. |
---|---|
المؤلفون: | Polley MC; Mei-Yin C. Polley, PhD, NRG Oncology Statistics and Data Management Center, Philadelphia, PA; Thierry Gorlia, PhD, EORTC, Brussels, Belgium; Andy B. Lassman, MD, Division of Neuro-Oncology, Department of Neurology, Columbia University Vagelos College of Physicians and Surgeons, Herbert Irving Comprehensive Cancer Center, NewYork-Presbyterian Hospital, New York, NY; and Martin J. van den Bent, MD, Department of Neurology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., Gorlia T; Mei-Yin C. Polley, PhD, NRG Oncology Statistics and Data Management Center, Philadelphia, PA; Thierry Gorlia, PhD, EORTC, Brussels, Belgium; Andy B. Lassman, MD, Division of Neuro-Oncology, Department of Neurology, Columbia University Vagelos College of Physicians and Surgeons, Herbert Irving Comprehensive Cancer Center, NewYork-Presbyterian Hospital, New York, NY; and Martin J. van den Bent, MD, Department of Neurology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., Lassman AB; Mei-Yin C. Polley, PhD, NRG Oncology Statistics and Data Management Center, Philadelphia, PA; Thierry Gorlia, PhD, EORTC, Brussels, Belgium; Andy B. Lassman, MD, Division of Neuro-Oncology, Department of Neurology, Columbia University Vagelos College of Physicians and Surgeons, Herbert Irving Comprehensive Cancer Center, NewYork-Presbyterian Hospital, New York, NY; and Martin J. van den Bent, MD, Department of Neurology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., van den Bent MJ; Mei-Yin C. Polley, PhD, NRG Oncology Statistics and Data Management Center, Philadelphia, PA; Thierry Gorlia, PhD, EORTC, Brussels, Belgium; Andy B. Lassman, MD, Division of Neuro-Oncology, Department of Neurology, Columbia University Vagelos College of Physicians and Surgeons, Herbert Irving Comprehensive Cancer Center, NewYork-Presbyterian Hospital, New York, NY; and Martin J. van den Bent, MD, Department of Neurology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands. |
المصدر: | Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2023 Feb 01; Vol. 41 (4), pp. 934-935. Date of Electronic Publication: 2022 Oct 03. |
نوع المنشور: | Letter; Comment |
اللغة: | English |
بيانات الدورية: | Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: PubMed not MEDLINE; MEDLINE |
أسماء مطبوعة: | Publication: 2003- : Alexandria, VA : American Society of Clinical Oncology Original Publication: New York, N.Y. : Grune & Stratton, c1983- |
التعليقات: | Comment on: J Clin Oncol. 2023 Feb 1;41(4):933-934. (PMID: 36191285) |
تواريخ الأحداث: | Date Created: 20221003 Date Completed: 20230131 Latest Revision: 20230403 |
رمز التحديث: | 20231215 |
DOI: | 10.1200/JCO.22.01874 |
PMID: | 36191279 |
قاعدة البيانات: | MEDLINE |
تدمد: | 1527-7755 |
---|---|
DOI: | 10.1200/JCO.22.01874 |